SUMO Rules: Regulatory Concepts and Their Implication in Neurologic Functions

被引:38
作者
Droescher, Mathias [1 ]
Chaugule, Viduth K. [1 ]
Pichler, Andrea [1 ]
机构
[1] Max Planck Inst Immunobiol & Epigenet, Dept Epigenet, D-79108 Freiburg, Germany
关键词
SUMO; E1 activating enzyme; E2 conjugating enzyme; E3; ligases; SUMO-specific proteases; SIM; SUMO consensus; SUMO paralogs; Deregulation; Neurological disorders; UBIQUITIN-CONJUGATING ENZYME; IN-VIVO IDENTIFICATION; E3 LIGASE ACTIVITY; DNA-DAMAGE; TUMOR-SUPPRESSOR; TRANSCRIPTION FACTORS; MODIFICATION PATHWAY; PROTEIN SUMOYLATION; NEGATIVE REGULATION; MASS-SPECTROMETRY;
D O I
10.1007/s12017-013-8258-6
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Posttranslational modification of proteins by the small ubiquitin-like modifier (SUMO) is a potent regulator of various cellular events. Hundreds of substrates have been identified, many of them involved in vital processes like transcriptional regulation, signal transduction, protein degradation, cell cycle regulation, DNA repair, chromatin organization, and nuclear transport. In recent years, protein sumoylation increasingly attracted attention, as it could be linked to heart failure, cancer, and neurodegeneration. However, underlying mechanisms involving how modification by SUMO contributes to disease development are still scarce thus necessitating further research. This review aims to critically discuss currently available concepts of the SUMO pathway, thereby highlighting regulation in the healthy versus diseased organism, focusing on neurologic aspects. Better understanding of differential regulation in health and disease may finally allow to uncover pathogenic mechanisms and contribute to the development of disease-specific therapies.
引用
收藏
页码:639 / 660
页数:22
相关论文
共 270 条
[1]
Nse2, a component of the Smc5-6 complex, is a SUMO ligase required for the response to DNA damage [J].
Andrews, EA ;
Palecek, J ;
Sergeant, J ;
Taylor, E ;
Lehmann, AR ;
Watts, FZ .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (01) :185-196
[2]
RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism [J].
Aslanukov, Azamat ;
Bhowmick, Reshma ;
Guruju, Mallikarjuna ;
Oswald, John ;
Raz, Dorit ;
Bush, Ronald A. ;
Sieving, Paul A. ;
Lu, Xinrong ;
Bock, Cheryl B. ;
Ferreira, Paulo A. .
PLOS GENETICS, 2006, 2 (10) :1653-1665
[3]
PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes [J].
Azuma, Y ;
Arnaoutov, A ;
Anan, T ;
Dasso, M .
EMBO JOURNAL, 2005, 24 (12) :2172-2182
[4]
The SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1 modification of DNA Topoisomerase II [J].
Bachant, J ;
Alcasabas, A ;
Blat, Y ;
Kleckner, N ;
Elledge, SJ .
MOLECULAR CELL, 2002, 9 (06) :1169-1182
[5]
Herpes simplex virus 1 ICPO co-localizes with a SUMO-specific protease [J].
Bailey, D ;
O'Hare, P .
JOURNAL OF GENERAL VIROLOGY, 2002, 83 :2951-2964
[6]
The yeast SUMO isopeptidase Smt4/Ulp2 and the polo kinase Cdc5 act in an opposing fashion to regulate sumoylation in mitosis and cohesion at centromeres [J].
Baldwin, Melissa L. ;
Julius, Jeffrey A. ;
Tang, Xianying ;
Wang, Yanchang ;
Bachant, Jeff .
CELL CYCLE, 2009, 8 (20) :3406-3419
[7]
Structure determination of the small ubiquitin-related modifier SUMO-1 [J].
Bayer, P ;
Arndt, A ;
Metzger, S ;
Mahajan, R ;
Melchior, F ;
Jaenicke, R ;
Becker, J .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 280 (02) :275-286
[8]
Identification of a multifunctional binding site on Ubc9p required for Smt3p conjugation [J].
Bencsath, KP ;
Podgorski, MS ;
Pagala, VR ;
Slaughter, CA ;
Schulman, BA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (49) :47938-47945
[9]
Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1 [J].
Bernier-Villamor, V ;
Sampson, DA ;
Matunis, MJ ;
Lima, CD .
CELL, 2002, 108 (03) :345-356
[10]
SUMOylation in carcinogenesis [J].
Bettermann, Kira ;
Benesch, Martin ;
Weis, Serge ;
Haybaeck, Johannes .
CANCER LETTERS, 2012, 316 (02) :113-125